Attention: open in a new window. E-mailPrintPDF
In its non-consolidated financial report for 2018, chemical giant PKN Orlen intends to book a partial impairment reversal adjusting the value of investments in Orlen Upstream group estimated at approx.…

Order subscription to read this article




Order at
Order from our partners:

Call us:

Find us: